THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST CIRM Scholar Alessandra Rodriguez y Baena Through our new Strategic Plan, the California Institute for Regenerative Medicine (CIRM) will build inclusive participation opportunities for all stakeholders, from the students to the workforce to the patients. That said, it’s important to recognize the important work CIRM has already done … Continue reading How these scholars are growing the regenerative medicine field in California
Author: Esteban Cortez
CIRM-funded stem cell clinical trial patients: Where are they now?
Ronnie with his parents Pawash Priyank and Upasana Thakur. Since its launch in 2004, the California Institute for Regenerative Medicine (CIRM) has been a leader in growing the stem cell and regenerative medicine field while keeping the needs of patients at the core of its mission. To date, CIRM has: Advanced stem cell research and therapy development for … Continue reading CIRM-funded stem cell clinical trial patients: Where are they now?
Empowering and connecting California’s research ecosystem through shared labs
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST A shared stem cell laboratory at UCLA The California Institute for Regenerative Medicine (CIRM) has set ambitious goals in its new 5-year strategic plan. Made possible by renewed funding through Proposition 14, the plan lays out a roadmap for CIRM as the agency continues to advance … Continue reading Empowering and connecting California’s research ecosystem through shared labs
A CIRM-funded therapy for a deadly blood cancer gets approval for Phase 3 clinical trial
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Michael Wang, MD (right) of the Department of Lymphoma & Myeloma at MD Anderson Cancer Center will lead the Phase 3 clinical Oncternal Therapeutics, Inc. is celebrating an encouraging milestone at the start of the new year following a successful End-of-Phase 2 meeting with the FDA. Specifically, the FDA agreed on key … Continue reading A CIRM-funded therapy for a deadly blood cancer gets approval for Phase 3 clinical trial
The Most Read Stem Cellar Blog Posts of 2021
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST This year was a momentous one for the California Institute for Regenerative Medicine (CIRM). We celebrated the passage of Proposition 14, and as a result, introduced our new strategic plan and added a group of talented individuals to our team. We shared our most exciting updates and newsworthy stories—topics ranging from stem cell research to diversity … Continue reading The Most Read Stem Cellar Blog Posts of 2021
Researchers develop a stem cell-based implant for cartilage restoration and treating osteoarthritis
The Plurocart’s scaffold membrane seeded with stem cell-derived chondrocytes. Image courtesy of USC Photo/Denis Evseenko. THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Researchers at the Keck School of Medicine of USC have used a stem cell-based bio-implant to repair cartilage and delay joint degeneration in a large animal model. This paves the way … Continue reading Researchers develop a stem cell-based implant for cartilage restoration and treating osteoarthritis
Newly-developed organoid mimics how gut and heart tissues arise cooperatively from stem cells
Gladstone Senior Investigator Todd McDevitt, PhD said this first-of-its-kind organoid could serve as a new tool for laboratory research and improve our understanding of how developing organs and tissues cooperate and instruct each other.
Now-Defunct For-Profit Stem Cell Clinic Ordered to Pay $5.1 Million for Scamming Patients Through False Advertising
This blog is also available as an AUDIO CAST Photo of New York Attorney General Letitia James courtesy Wikimedia commons A now-defunct New York City for-profit stem cell clinic — Park Avenue Stem Cell — was order by court to pay $5.1 million in potential consumer restitution, penalties, and costs for fraudulently and illegally advertising … Continue reading Now-Defunct For-Profit Stem Cell Clinic Ordered to Pay $5.1 Million for Scamming Patients Through False Advertising
The Stem Cellar 